Page 120 - MemoriaCIBER-2017ENG

Communicable disease prevention, surveillance
and control
Coordinator: Pere Godoy García*
Details of some of the most relevant projects in the CIBERESP’s PREVICET programme are given below:
• January 2017 saw the start of the project entitled “Factors associated with outbreaks of acute gastroenteritis by norovirus” (FIS-PI16/02005) in which the groups of Á Domínguez and C Rius (PI Angela Domínguez) took part
• The project known as “E ectiveness of vaccine against pertussis in pregnant women: case and control study in Catalonia and Navarre” (FIS-PI15/01348) was also continued, with the participation of the groups led by Á Domínguez, J Castilla, C Rius and M C Muñoz’s group (PI Pere Godoy) and which will also be active during 2018
• In 2017 the results of “E ectiveness of anti- u vaccine and anti-pneumococcal polysaccha- ride 23-valent in ≥65 years” (FIS-PI12/02079) were published The groups of Á Domínguez, E Calderón, J Castilla, C Rius, M Morales took part in this Five articles were published
• European projects “Setting up a sentinel system to assess the burden of whooping cough in EU/ EEA” and “Assessing the impact of conjugate vaccines on pneumococcal disease in Eu- rope” nanced by the ECDC
• The group led by Amparo Larrauri, along with other groups, is taking part in two European projects on the e ectiveness of the anti- u vaccine, one in primary care (Call for tender of the ECDC) and another in hospitalised patients (Horizon 2020 EU 634446) Six Q1 articles were published
• 2017 was the last year for the FIS project (FIS PI13/02123) Two articles were published on the impact and e ectiveness of the vaccine and the research into e ectiveness contributed to the GIVE 2016 reports (The Global In uenza Vaccine E ectiveness Collaboration)
• “Risk of complications in pregnant women admitted to hospital with serious u infections”: project: article being reviewed
• “Research into Enterovirus infections causing severe neurological and systemic pathologies in the child population”: article on the implication of EV-D68
• Project entitled “Epidemiological and virological analyses of the viral agents included in the triple viral vaccine, new challenges” (AESI2015: PI15CIII/00023): Group J E Echevarría (PI Fernando de Ory and Aurora Fernández) and A Larrauri’s group; two international articles on parotitis and the value of IgG titration for diagnosis of infection in vaccinated persons
• VIROBAT3 (SAF2013-47194-P) Project: J E Echevarría’s group (PI Juan E Echevarría) and J Figuerola’s group, on rabies and other viruses associated with bats Two articles, one on the phylogeography of European bat virus type 1 and another describing the presence of Bartonella in Spanish bats The VIROBAT 4 project has been granted enabling working in this approach to go on Also J E Echevarría’s group and J Figuerola’s group have published an article on diagnosis of infection by Zika virus in the Spanish Olympic team of Rio de Janeiro”
* Until December the Coordinator was Joan Caylà Buqueras
120 CIBER ANNUAL REPORT 2017